发明名称 |
Nitrated-fatty acids modulation of type II diabetes |
摘要 |
Nitro oleic acid and related metabolites are agonists of PPAR-γ. Surprisingly, nitro oleic acid is a more potent agonist of PPAR-γ, relative to nitro linoleic acid. Thus, nitro oleic acid and its metabolites, as well as their pharmaceutically acceptable salts and prodrug forms, are candidate therapeutics for the treatment of type-2 diabetes, which results from insulin resistance accompanying the improper functioning of PPAR-γ. |
申请公布号 |
US9186408(B2) |
申请公布日期 |
2015.11.17 |
申请号 |
US201414244741 |
申请日期 |
2014.04.03 |
申请人 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
发明人 |
Freeman Bruce A.;Schopfer Francisco J. |
分类号 |
A61K31/201;A61K45/06;A61K31/20 |
主分类号 |
A61K31/201 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. A method for controlling weight gain, comprising the steps of:
administering to a subject in need thereof a pharmaceutical composition comprising an active agent selected from nitro oleic acid and a metabolite of nitro oleic acid, or a pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable excipient, carrier, or combination thereof; and repeating the step of administering at least once. |
地址 |
Pittsburgh PA US |